Nico.lab, headquartered in Amsterdam, is a game changer in the industry and dedicated to improving stroke care by speeding up the diagnosis and improving treatment decisions. Our technology is based on cutting edge AI technology and the latest clinical research. Our creative and highly skilled team works dedicated in an evidence-based way to bring AI into clinical practice.
This webpage is for (potential) investors to have access to the latest shareholder and company information. Announcements, annual reports, and important information can be found here.